New Clinical Data Demonstrates Three Years of Continuous Treatment with Dual-Acting LEQEMBI (lecanemab-irmb) Continues to Significantly Benefit Early Alzheimer's Disease Patients Presented at AAIC 2024 Jul 31, 2024 12:59 HKT/SGT Read More
Dual-action therapy shows promise against aggressive oral cancer Jul 30, 2024 20:00 HKT/SGT Read More
Update on Regulatory Review of Lecanemab for Early Alzheimer's Disease in the European Union Jul 29, 2024 16:59 HKT/SGT Read More
OmniGuide Holdings Announces Successful Completion of Patient Study for Revolutionary iSTONE(TM) Laser-Guided Lithotripsy Technology Jul 26, 2024 20:05 HKT/SGT Read More
British Veterinary Association Ends Opposition to Vegan Diets for Dogs Jul 26, 2024 02:00 HKT/SGT Read More
Femto Pioneering US FemTech to Introduce Flagship Wellness Product at The AVN Expo in Las Vegas Jul 25, 2024 21:00 HKT/SGT Read More
Eisai and EcoNaviSta Enter into Business Alliance Agreement Aimed at Building a Dementia Ecosystem and Commence Collaboration Jul 25, 2024 09:30 HKT/SGT Read More
CGFNS International Joins WHO Stakeholder Network to Advance Rehabilitation Care Jul 23, 2024 22:00 HKT/SGT Read More
Eisai to Present Dual-Acting Lecanemab Three-Year Efficacy and Safety Data and Discuss Long-Term Outcomes of Continued Treatment at the Alzheimer's Association International Conference 2024 Jul 23, 2024 19:23 HKT/SGT Read More
Sirnaomics Announces Completion of IND-Enabling Studies of Safety and Efficacy for STP125G with NHP Models, Targeting ApoC3 for Treatment of Cardiovascular Diseases Jul 23, 2024 19:16 HKT/SGT Read More
Sirnaomics宣布完成针对靶向APOC3用于治疗心血管疾病的STP125G 在非人灵长类动物模型中安全性和有效性的IND准备阶段研究 Jul 23, 2024 18:26 HKT/SGT Read More
Sirnaomics宣佈完成針對靶向APOC3用於治療心血管疾病的STP125G 在非人靈長類動物模型中安全性和有效性的IND準備階段研究 Jul 23, 2024 17:52 HKT/SGT Read More
Avance Clinical Appoints Asia Regional Director as Part of Global Expansion Program Jul 23, 2024 16:00 HKT/SGT Read More
Q&M Dental Group Advanced "Treatment Plan" AI-Module Released Today Jul 23, 2024 10:30 HKT/SGT Read More